Evidence for Prostate Cancer-Associated Diagnostic Marker-1: Immunohistochemistry and in Situ Hybridization Studies

Clinical Cancer Research

Volumn 10, Issue 7, 2004, Pages 2452-2458

  Ohkia, Akira ^b   Hu, Youji ^b   Wang, Min ^b   Garcia, Fernando U ^b   Stearns, Mark E ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

POLYCLONAL ANTIBODY; PROSTATE CANCER ASSOCIATED DIAGNOSTIC MARKER 1 PROTEIN; TUMOR MARKER; UNCLASSIFIED DRUG;

ANTIBODY LABELING; ARTICLE; CANCER CELL CULTURE; EPITHELIUM CELL; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; MOLECULAR RECOGNITION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATIC INTRAEPITHELIAL NEOPLASIA;

ANTIGENS, NEOPLASM; BLOTTING, WESTERN; CELL LINE; CELL LINE, TUMOR; HUMANS; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; PROSTATE; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS; RECOMBINANT PROTEINS; RNA, MESSENGER; SOFTWARE; TUMOR MARKERS, BIOLOGICAL;

EID: 1842478441     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-03-0170     Document Type: Article

References (29)

1. Smith JR, Frieje D, Carpten JD, et al. Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search. Science (Wash DC) 2001;274:1371-4.
2. Su ZZ, Lin J, Shen R, et al. Surface-epitope masking and expression cloning identifies the human prostate carcinoma tumor antigen gene PCTA-1, a member of the galectin gene family. Proc Natl Acad Sci USA 1996;88:7252-7.
3. Gronenberg H, Isaacs SD, Smith JR, et al. J Am Med Assoc 1997;278:1251-5.
4. Bright RK, Vocke CD, Emmert-Buck MR, et al. Generation and genetic characterization of immortal human prostate epithelial cell lines derived from primary cancer specimens. Cancer Res 1997;57:995-1002.
5. Wang M, Stearns ME. Isolation and characterization of PC-3 human prostatic tumor sublines which preferentially metastasize to select organs in SCID mice. Differentiation 1991;48:115-25.
6. Weijerman PC, Konig JJ, Wong ST, Niesters HGM, Peehl DM. Lipofection-mediated immortalization of human prostatic epithelial cells of normal and malignant origin using human papillomavirus type 18 DNA. Cancer Res 1994;54:5579-83.
7. Aoyagi K, Shima I, Wang M, et al. Specific transcription factors prognostic for prostate cancer progression. Clin Cancer Res 1998;4:2153-60.
8. Tokunaga A, Kondo E, Fukuoka T, et al. Excitability of spinal cord and grackle nucleus neurons in rats with chronically injured sciatic nerve examined by c-fos expression. Brain Res 1999;847:321-31.
9. Stearns ME, Stearns M. Immunohistochemical studies of activated MMP-2 expression in human prostate cancer. Oncol Res 1996;8:63-7.
10. Wood M, Fudge K, Mohler JL, et al. In situ hybridization studies of metalloproteinases 2 and 9 and TIMP-1 and TIMP-2 expression in human prostate cancer. Clin Exp Metastasis 1997;15:246-58.
11. Miyajima Y, Nakano R, Morimatsu M. Analysis of expression of matrix metalloproteinases-2 and -9 in hypopharyngeal squamous cell carcinoma by in situ hybridization. Ann Otol Rhinol Laryngol 1995;104:678-84.
12. Fudge K, Wang CY, Stearns ME. Immunohistochemistry analysis of PDGF A/B chains and PDGF α and β receptor expression in BPH and Gleason graded human prostate adenocarcinomas. Mod Pathol 1994;7:549-54.
13. DeMascarel I, Soubeyran I, MacGrogan G, et al. Immunohistochemical analysis of estrogen receptors in 938 breast carcinomas. Appl Immunohistochem 1995;3:222-31.
14. MacGrogan G, Soubeyran I, De Mascarel I, et al. Immunohistochemical detection of progesterone receptors in breast invasive ductal carcinomas. Appl Immunohistochem 1996;4:219-27.
15. Battifora H, Gaffey M, Esteban J, et al. Immunohistochemical assay of neu/c-erbB-2 oncogene product in paraffin-embedded tissues in early breast cancer. Retrospective follow-up study of 245 stage I and II cases. Mod Pathol 1991;4:466-74.
16. Sundblad AS, Pellicer EM, Ricci L. Carcinoembryonic antigen expression in stages I and II breast cancer: its relationship and clinicopathologic factors. Hum Pathol 1996;27:297-301.
17. Barbareshchi M. Prognostic value of the immunohistochemical expression of p53 in breast carcinomas. A review of the literature involving over 9000 patients. Appl Immunohistochem 1996;4:106-11.
18. Wesidner N, Moore DH, Vartanian R. Correlation of Ki-67 antigen expression with mitotic figure index and tumor grade in breast carcinomas using the novel "paraffin"-reactive MIB-1 antibody. Hum Pathol 1994;25:337-42.
19. Joensuu H, Pylkkanen L, Toikkanen S. Bcl-2 protein expression and long term survival in breast cancer. Am J Pathol 1994;145:1191-8.
20. Fernandez-Pol JA, Klos DJ, Hamilton PD. A growth factor inducible gene encoding a novel nuclear protein with zinc-finger structure. J Biol Chem 1993;268:21198-204.
21. Fernandez-Pol JA, Klos DJ, Hamilton PD. Metallopanstimulin gene product produced in a Bacculovirus expression system is a nuclear phosphoprotein that binds to DNA. Cell Growth Differ 1994;5:821-5.
22. Fernandez-Pol JA. Metallopanstimulin as a novel tumor marker in sera of patients with various types of common cancers: implications for prevention and therapy. Anticancer Res 1996;16:2177-86.
23. Chiao PJ, Shin DM, Sacks PG, Hong WK, Tainsky MA. Elevated expression of the ribosomal protein S2 gene in human tumors. Mol Carcinog 1992;5:219-31.
24. Chan Y-L, Olvera J, Paz V, Wool IG. The primary structures of rat ribosomal proteins S3a (the v-fos transformation effector) and of S3b. Biochem Biophys Res Commun 1996;228:141-7.
25. Chan Y-L, Diaz JJ, Denoroy L, Madjar JJ, Wool IG. The primary structure of rat ribosomal protein L10: relationship to a Jun-binding protein and to a putative Wilms' tumor suppressor. Biochem Biophys Res Commun 1996;225:952-6.
26. Wool IG. Extra ribosomal functions of ribosomal proteins. Trends Biochem Sci 1996;21:164-5.
27. Wool IG. Extra ribosomal functions of ribosomal proteins. In: Green R, Schroeder R, editors. The ribosomal RNA and group I introns. Austin, TX: R. G. Landes Co.; 1997. p. 153-78.
28. Wool IG, Chan Y-L, Gluck A. Structure and evolution of mammalian ribosomal proteins (review). Biochem Cell Biol 1995;73:33-47.
29. Vaarala MH, Porvari KS, Kyllonen AP, et al. Several genes encoding ribosomal proteins are overexpressed in prostate-cancer cell lines: confirmation of L7a and L37 overexpression in prostate cancer tissue samples. Int J Cancer 1998;78:27-32.